Disease-Free SurvivalSurvival RatePrognosisNeoplasm Recurrence, LocalNeoplasm StagingBreast NeoplasmsSurvival AnalysisCombined Modality TherapyLymphatic MetastasisTreatment OutcomeFollow-Up StudiesRetrospective StudiesKaplan-Meier EstimateAntineoplastic Combined Chemotherapy ProtocolsSEER ProgramTumor Markers, BiologicalChemotherapy, AdjuvantRadiotherapy, AdjuvantImmunohistochemistryCell SurvivalProportional Hazards ModelsRadiotherapy DosageFluorouracilTime FactorsCarcinoma, Squamous CellNeoplasm InvasivenessCyclophosphamideColorectal NeoplasmsCarcinoma, Ductal, BreastMultivariate AnalysisCarcinomaRecurrenceLiver NeoplasmsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenReceptor, erbB-2Prospective StudiesPredictive Value of TestsGene Expression Regulation, NeoplasticRisk FactorsSurvivalNeoplasm MetastasisCisplatinLung NeoplasmsAntineoplastic AgentsGraft SurvivalNeoplasm GradingVincristineDoxorubicinNeoadjuvant TherapyBone NeoplasmsRemission InductionDisease ProgressionEtoposideChemoradiotherapyDrug Administration ScheduleCarcinoma, Non-Small-Cell LungCohort StudiesOvarian NeoplasmsSalvage TherapyReceptors, ProgesteroneMethotrexateSarcomaRadiotherapyHead and Neck NeoplasmsFree RadicalsLymphoma, Non-HodgkinPrednisoneLymph Node ExcisionBrachytherapyActuarial AnalysisAge FactorsCarboplatinHodgkin DiseaseCarcinoma, HepatocellularLymph NodesNeoplasms, Germ Cell and EmbryonalNeoplasm ProteinsHematopoietic Stem Cell TransplantationPancreatic NeoplasmsTransplantation, AutologousOsteosarcomaNeoplasm, ResidualTransplantation, HomologousPaclitaxelBrain NeoplasmsStomach NeoplasmsRisk AssessmentTamoxifenAntineoplastic Agents, HormonalRectal NeoplasmsAntibodies, MonoclonalUterine Cervical NeoplasmsDose FractionationCell Line, TumorReverse Transcriptase Polymerase Chain ReactionMediastinal NeoplasmsDeoxycytidineApoptosis